3/4
09:38 am
ctor
Citius Oncology Announces Preliminary Topline Phase 1 Data from Study of LYMPHIR™ (E7777) Dosing Prior to Commercial CAR-T Therapy in High-Risk Diffuse Large B-Cell Lymphoma [Yahoo! Finance]
Medium
Report
Citius Oncology Announces Preliminary Topline Phase 1 Data from Study of LYMPHIR™ (E7777) Dosing Prior to Commercial CAR-T Therapy in High-Risk Diffuse Large B-Cell Lymphoma [Yahoo! Finance]
3/4
09:15 am
ctor
Citius Oncology Announces Preliminary Topline Phase 1 Data from Study of LYMPHIR™ (E7777) Dosing Prior to Commercial CAR-T Therapy in High-Risk Diffuse Large B-Cell Lymphoma
Neutral
Report
Citius Oncology Announces Preliminary Topline Phase 1 Data from Study of LYMPHIR™ (E7777) Dosing Prior to Commercial CAR-T Therapy in High-Risk Diffuse Large B-Cell Lymphoma
2/24
09:54 am
ctor
Citius Oncology (CTOR) Expands LYMPHIR Distribution to Europe Through Exclusive Agreement With Uniphar [Yahoo! Finance]
Low
Report
Citius Oncology (CTOR) Expands LYMPHIR Distribution to Europe Through Exclusive Agreement With Uniphar [Yahoo! Finance]
2/13
08:13 am
ctor
Citius Oncology, Inc. Announces First Reported Revenue Following Successful Launch of LYMPHIR™ [Yahoo! Finance]
Low
Report
Citius Oncology, Inc. Announces First Reported Revenue Following Successful Launch of LYMPHIR™ [Yahoo! Finance]
2/13
08:00 am
ctor
Citius Oncology, Inc. Announces First Reported Revenue Following Successful Launch of LYMPHIR™
Neutral
Report
Citius Oncology, Inc. Announces First Reported Revenue Following Successful Launch of LYMPHIR™
2/12
07:01 am
ctor
Citius Oncology and Uniphar sign European distribution deal for Lymphir [Yahoo! Finance]
Low
Report
Citius Oncology and Uniphar sign European distribution deal for Lymphir [Yahoo! Finance]
2/11
08:00 am
ctor
Citius Oncology Expands International Distribution of LYMPHIR™ to European Union Through Exclusive Agreement with Uniphar
Medium
Report
Citius Oncology Expands International Distribution of LYMPHIR™ to European Union Through Exclusive Agreement with Uniphar
1/5
10:30 am
ctor
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Citius Oncology, Inc. (NASDQ: CTOR)
Neutral
Report
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Citius Oncology, Inc. (NASDQ: CTOR)
12/23
05:16 pm
ctor
Citius Oncology, Inc. Reports Fiscal Year 2025 Financial Results and Provides Business Update [Yahoo! Finance]
Medium
Report
Citius Oncology, Inc. Reports Fiscal Year 2025 Financial Results and Provides Business Update [Yahoo! Finance]
12/23
04:30 pm
ctor
Citius Oncology, Inc. Reports Fiscal Year 2025 Financial Results and Provides Business Update
Medium
Report
Citius Oncology, Inc. Reports Fiscal Year 2025 Financial Results and Provides Business Update
12/10
04:59 pm
ctor
Citius Oncology Announces Closing of $18 Million Concurrent Registered Direct Offering and Private Placement Priced At-The-Market Under Nasdaq Rules [Yahoo! Finance]
Low
Report
Citius Oncology Announces Closing of $18 Million Concurrent Registered Direct Offering and Private Placement Priced At-The-Market Under Nasdaq Rules [Yahoo! Finance]
12/10
04:30 pm
ctor
Citius Oncology Announces Closing of $18 Million Concurrent Registered Direct Offering and Private Placement Priced At-The-Market Under Nasdaq Rules
Low
Report
Citius Oncology Announces Closing of $18 Million Concurrent Registered Direct Offering and Private Placement Priced At-The-Market Under Nasdaq Rules
12/9
08:30 am
ctor
Citius Oncology Announces $18 Million Concurrent Registered Direct Offering and Private Placement Priced At-The-Market Under Nasdaq Rules
High
Report
Citius Oncology Announces $18 Million Concurrent Registered Direct Offering and Private Placement Priced At-The-Market Under Nasdaq Rules